x

Search for a clinical trial

* (*) mandatory field

151 Result(s)

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trials

FINLAND

Finland
HELSINKI

BNCT to treat glioma that has progressed following radiotherapy
HUCH - Helsinki University Central Hospital
Department of Oncology

FRANCE

BRETAGNE
RENNES

FRANCE

ILE-DE-FRANCE
BOBIGNY

A Phase II multicenter study of immunotherapy with CpG-ODN in patients with glioblastoma -Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Randomized Phase III Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Glivec - Hydrea in recurrent glioblastoma (Phase II) - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

ILE-DE-FRANCE
BOBIGNY

Recruiting trial
Radiotherapy and Temozolomide with or without Avastin for treatment of de novo glioblastoma (Phase III)
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCE

ILE-DE-FRANCE
PARIS

Chemotherapy study of temozolomide-bevacizumab treatment of supratentorial glioblastoma patients more than 70 years old with altered functional state (Phase II).
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCE

ILE-DE-FRANCE
PARIS

Phase III study chemotherapy vs radiotherapy in low-grade glioma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A Prospective, Multi-center Phase III Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed Glioblastoma Multiforme
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCE

ILE-DE-FRANCE
PARIS

EORTC protocol 26083 : Randomized phase II of CCNU (Lomustine) versus CCNU (Lomustine) - dasatinib in patients with recurrent glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Multicentric Randomized Phase II: Immunotherapy With CpG-ODN in Malignant Glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Consultation de Neurochirurgie

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Ongoing trial
BIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (Phase II) - FR
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent #

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Cooperative multicenter study for children and adolescents with low grade glioma - FR
CLCC Institut Gustave Roussy
Département de pédiatrie - UPRES EA 3535

FRANCE

MIDI-PYRENEES
TOULOUSE

PhaseI-II trial to assess the radiosensitizing effect of Zarnestra in patients with glioblastoma multiforme
IUCT Oncopole - CLCC Institut Claudius Regaud
Département de radiothérapie

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

A randomized multicentric phase II trial immunotherapy of de novo glioblastoma by CpG-ODN
CHU de Marseille - Hôpital de la Timone
Service de neuro-oncologie

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

FRANCE

RHONE-ALPES
BRON

Recruiting trial
Ongoing trial
Randomized, Prospective, Multicenter Blinding Singles With Arm A and Arm B Innovative Strategy Strategy Conventional (Phase III) - FR
CHU de Lyon HCL - GH Est-Hôpital Neurologique P. Wertheimer
Neurochirurgie B - Unité multidisciplinaire de Chirurgie Tumorale de la base du Crâne

FRANCE

RHONE-ALPES
LYON

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
ULM

GERMANY

Bayern
MÜNCHEN

Recruiting trial
Ongoing trial
GlioCave/NOA17: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (Phase 2) - DE
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie

GERMANY

Bayern
REGENSBURG

GERMANY

Nordrhein-Westfalen
BONN

GERMANY

Nordrhein-Westfalen
BONN

NOA-05: Phase II trial of Procarbazine and Lomustine in Gliomatosis cerebri - Terminated
Universitätsklinikum Bonn
Klinik und Poliklinik für Neurologie

GERMANY

Nordrhein-Westfalen
ESSEN

IRELAND

County Dublin
DUBLIN

Phase II Study of High-Dose Methotrexate in Children With Residual Ependymoma - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

ITALY

LOMBARDIA
MILANO

Ongoing trial
Second italian protocol of diagnosis and treatment of childhood ependymoma
Fondazione IRCCS Istituto Nazionale dei Tumori
Unità di Neuro-Oncologia Pediatrica

NETHERLANDS

Limburg
MAASTRICHT

NETHERLANDS

Noord-Holland
AMSTERDAM

NETHERLANDS

Zuid-Holland
DEN HAAG

Cognitieve Rehabilitatie van Glioom Patiënten
MCH - Medisch Centrum Haaglanden, locatie Westeinde
Afdeling Neuro-Oncologie

NETHERLANDS

Zuid-Holland
ROTTERDAM

Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma
Erasmus MC - Erasmus Medisch Centrum
Afdeling Kinderoncologie/hematologie

POLAND

Warszawa
WARSAW

Recruiting trial
Ongoing trial
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PL
Instytut "Pomnik-Centrum Zdrowia Dziecka"
Klinika Onkologii IP-CZD

PORTUGAL

NORTE
PORTO

Recruiting trial
Ongoing trial
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma - PT
Centro Hospitalar de S. João, EPE
Unidade de Hematologia e Oncologia Pediátrica

SPAIN

Andalucía
SEVILLA

Recruiting trial
Ongoing trial
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with Ependymoma (Phase II-III) - ES
Hospital Universitario Virgen del Rocío
Unidad de Gestión Clínica Intercentros de Oncología Pediátrica

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK

UNITED KINGDOM

Nottinghamshire
NOTTINGHAM

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

CNS 2007 04: A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide With Radiotherapy in Diffuse Pontine Gliomas - UK (Completed)
The Great North Children's Hospita, Royal Victoria Infirmary
Sir James Spence Institute of Child Health

UNITED KINGDOM

West Midlands
BIRMINGHAM

UNITED KINGDOM

West Midlands
BIRMINGHAM

CNS 2005 03: Phase II Study of High-Dose Methotrexate in Children with Residual Ependymoma (Completed)
Birmingham Children's Hospital NHS Foundation Trust
Department of Oncology

UNITED KINGDOM

West Yorkshire
LEEDS

UNITED KINGDOM

West Yorkshire
LEEDS

CNS 2001 04: Phase II study of Intravenous Etoposide in Patients with Relapsed Ependymoma
St James's University Hospital
Regional Paediatric Oncology Unit

Multinational clinical trials

GERMANY

Baden-Württemberg
TÜBINGEN

UNITED KINGDOM

Leicestershire
LEICESTER

Ongoing trial
CNS 2004 03: Cooperative Multicentre Study For Children And Adolescents With Low Grade Glioma (Phase III) (coordination)
Leicester Univ. Hosp. NHS - Leicester Royal Infirmary
University Hospitals of Leicester NHS Trust Headquarters